These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2727598)

  • 1. [Determination of the macromolecules in the extracellular matrix or of their antibodies in biological fluids in joint disease].
    Hartmann DJ; Ricard-Blum S; Ville G
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):187-9. PubMed ID: 2727598
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology of articular cartilage.
    Goldberg VM; Kresina TF
    J Rheumatol; 1987 May; 14 Spec No():73-6. PubMed ID: 2442391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers.
    Brandt KD
    J Rheumatol Suppl; 1989 Aug; 18():39-42. PubMed ID: 2681766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immune complexes and collagen type-specific antibodies in sera and synovial fluids of horses with secondary osteoarthritis.
    Niebauer GW; Wolf B; Yarmush M; Richardson DW
    Am J Vet Res; 1988 Aug; 49(8):1223-7. PubMed ID: 3178020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Articular cartilage and osteoarthritis.
    Buckwalter JA; Mankin HJ; Grodzinsky AJ
    Instr Course Lect; 2005; 54():465-80. PubMed ID: 15952258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ
    Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT; Page Thomas DP; Hazleman B
    Int J Tissue React; 1987; 9(4):349-54. PubMed ID: 3497901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fluid markers of cartilage changes in osteoarthritis.
    Thonar EJ; Shinmei M; Lohmander LS
    Rheum Dis Clin North Am; 1993 Aug; 19(3):635-57. PubMed ID: 8210579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of shear stress on articular chondrocyte metabolism.
    Lane Smith R; Trindade MC; Ikenoue T; Mohtai M; Das P; Carter DR; Goodman SB; Schurman DJ
    Biorheology; 2000; 37(1-2):95-107. PubMed ID: 10912182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis.
    Saxne T; Heinegård D
    J Rheumatol Suppl; 1995 Feb; 43():71-4. PubMed ID: 7752144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
    Brandt KD; Slowman-Kovacs S
    Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological markers of osteoarthritis].
    Thonar EJ; Manicourt DH
    Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):99S-102S. PubMed ID: 7858614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis.
    Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
    Connect Tissue Res; 2008; 49(2):62-7. PubMed ID: 18382891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions.
    Malemud CJ; Martel-Pelletier J; Pelletier JP
    J Rheumatol; 1987 May; 14 Spec No():20-2. PubMed ID: 3305934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of low molecular weight trypsin inhibitors in small samples of cartilage, cartilage extracts and synovial fluid by gel diffusion].
    Lindenhayn K; Haupt R; Heilmann HH; Wolf H
    Biomed Biochim Acta; 1987; 46(1):33-8. PubMed ID: 3107548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis.
    Tsuruha J; Masuko-Hongo K; Kato T; Sakata M; Nakamura H; Nishioka K
    Arthritis Rheum; 2001 Apr; 44(4):838-45. PubMed ID: 11315923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial fluid particle analysis in equine joint disease.
    Tew WP
    Mod Vet Pract; 1980 Dec; 61(12):993-7. PubMed ID: 7464782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.